Indrayani Biotech Limited

BSE: 526445
Indrayani Biotech Limited - agriculture in Chennai, Tamil Nadu, India. FY 2026 financials and compliance.
CIN L40100TN1992PLC129301 Incorporated 09 March 1992 ROC Chennai HQ Chennai, Tamil Nadu, India
Active Listed - BSE: 526445 Public Limited Company agriculture
Data last updated
Revenue · FY 2025
₹130.23 Cr
▼ 21.66% YoY
EBITDA · FY 2025
₹9.39 Cr
▼ 61.93% YoY
Net profit · FY 2025
-₹6.11 Cr
▼ 158.6% YoY
Authorised capital
₹65 Cr
Registered with MCA
Paid-up capital
₹45.54 Cr
Issued & subscribed
Open charges
₹22.15 Cr
Satisfied ₹63 Lakh
Company age
34 yrs
Est. 1992
Employees · EPFO
445
Latest available

About Indrayani Biotech Limited

Data last updated: 23 December 2025

Indrayani Biotech Limited is a public limited company based in Chennai, Tamil Nadu, India. It specialises in fertilizers and soil enhancers, a part of the broader agriculture sector. Incorporated on 09 March 1992, the company has been in operation for over 34 years.

Registered with ROC Chennai under CIN L40100TN1992PLC129301. Listed on BSE: 526445.

Capital: an authorised share capital of ₹65 Cr and a paid-up capital of ₹45.54 Cr. It is led by directors including Bokara Nagarajan Padmaja Priyadarshini and Muthukrishnan Ramesh.

Last AGM: 22 August 2024. Financial statements filed for year ended 31 March 2024. Office: Chennai, Tamil Nadu.

As per the financials filed for FY 2024, the company reported a revenue of ₹167.44 Cr, a growth of 0% compared to the previous year.

The company has a workforce of approximately 445 employees as per the latest available data. Its group structure includes 9 subsidiaries.

The company is associated with 1 brand - Indrayani Biotech. As per MCA filings, the company has open charges of ₹22.15 Cr and satisfied charges of ₹63 Lakh on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website indrayani.com.

Company Details of Indrayani Biotech Limited
CIN L40100TN1992PLC129301
Registration Number 129301
Incorporation Date 09 March 1992
ROC Chennai
Listing Status Listed (BSE: 526445)
Company Status Active
Date of Last AGM 22 August 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
Key People
Kasiraman Sayee Sundar Managing Director Muthukrishnan Ramesh Whole-Time Director Singarababu Indirakumar Whole-Time Director
Contact Details
  • Email
    *****@*****.com
  • Telephone
    +91-****-******
  • Website
    indrayani.com
  • Social Media
    **************
  • Registered Address
    Block 1 Module No.33 3Rd Floor Sidco Electronic Complex Thiru Vi Ka Industrial Estate G, Uindy, Chennai, Tamil Nadu, India – 600032
  • Industry
    Agriculture, Fertilizers & Soil Enhancers
Company report
Indrayani Biotech Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Indrayani Biotech Limited report

Financials, compliance, directors, charges, ownership and filings for Indrayani Biotech Limited in one report.

10-year financials Directors & ownership Charges & compliance

CIN History of Indrayani Biotech Limited

Indrayani Biotech Limited has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is L40100TN1992PLC129301, which is the unique identifier assigned by the Registrar of Companies.

CIN Status
L40100TN1992PLC129301 Current
L40100PN1992PLC065801 Previous
L24231PN1992PLC065801 Previous

Associated Brands with Indrayani Biotech Limited

Indrayani Biotech Limited operates one associated brand: Indrayani Biotech. These brands represent Indrayani Biotech Limited's diversified market presence and brand portfolio.

Brand Description Website
Indrayani Biotech
Diversified crop nutrition and protection solutions are provided for farmers. indrayani.com

Competitors & Alternatives of Indrayani Biotech Limited

Brands and companies operating in the same space as Indrayani Biotech Limited include Titan Biotech, IPL Biologicals, Univia and 7 more.

Competitor Description Location Founded
Titan Biotech Titan Biotech Biological products are manufactured and exported for various industries. Delhi, India, India 1992
IPL Biologicals IPL Biologicals Plant nutrition and protection products are manufactured and supplied. Gurugram, India, India 1994
Univia Univia Agri-input retailers are connected to farmers via a phygital network. Ahmedabad, India, India 2020
Sri Biotech Laboratories Sri Biotech Laboratories Crop improvement research and nutrient manufacturing are conducted. Hyderabad, India, India 1994
Capsber Capsber Diversified crop biological solutions are provided for farmers. Bengaluru, India, India 2022
Lab2Land Lab2Land Agrochemicals, fertilizers, and crop nutrition solutions are researched and developed. Hyderabad, India, India 2020
Criyagen Criyagen Develops innovative technologies for organic and bio-active farm inputs. Bengaluru, India, India 2008
Shivashakthi BioTechnologies Shivashakthi BioTechnologies Development and commercial production of plantlets and farm inputs Hyderabad, India, India 2001
Varsha Bioscience and Technology Varsha Bioscience and Technology Bio-pesticides, bio-fertilizers, and plant growth promoters are manufactured. Hyderabad, India, India 2003
Gokulam Biotech Gokulam Biotech Develops liquid-based bio products for organic farming and agriculture. Puducherry, India, India 2002

Business Activity of Indrayani Biotech Limited

Indrayani Biotech Limited is engaged in principal business activities including manufacturing and accommodation and food service, with detailed activities including electrical equipment, general purpose and special purpose machinery & equipment, transport equipment, food and beverage services provided by hotels, restaurants, caterers, etc.. The company has 2 registered principal business activity segments, demonstrating its operational diversity and market reach.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
C Manufacturing C10 Electrical equipment, General Purpose and Special purpose Machinery & equipment, Transport equipment *********
I Accommodation and Food Service I2 Food and beverage services provided by hotels, restaurants, caterers, etc. *********

Board of Directors of Indrayani Biotech Limited

Indrayani Biotech Limited is currently managed by 11 directors, with 28 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Bokara Nagarajan Padmaja Priyadarshini
Also directs: Dindigul Farm Product Limited, Homeplanguru Civil Consultants Private Limited
Director 26 Mar 2021 5 Years 3 Months Current
Muthukrishnan Ramesh Whole-Time Director 04 Jan 2021 5 Years 6 Months Current
Singarababu Indirakumar
Also directs: Ibl Investments Limited, Ibl Social Foundation
Whole-Time Director 01 Aug 2020 5 Years 11 Months Current
Dhinakaran Rajagopal
Also directs: Ibl Laksha Hospitals Llp, Fine Mart Private Limited, Vaasan Medical Center (India) Private Limited
Cfo 03 Apr 2025 1 Years 3 Months Current
Swaminathan
Also directs: Ibl Investments Limited, Hslprime Properties Private Limited, Sical Connect Limited
Whole-Time Director 01 Aug 2020 5 Years 11 Months Current
Nangavaram Mahadevan Ranganathan
Also directs: Dindigul Farm Product Limited, Sip Industries Limited, Garudrik Ai Private Limited
Director 20 Aug 2018 7 Years 10 Months Current
Showing 6 of 11 current directors. View all directors

Financials of Indrayani Biotech Limited FY 2025 filings available

Indrayani Biotech Limited reported revenue of ₹130.23 Cr (down 21.66% YoY) for FY 2025. Profit growth despite declining revenue indicates effective cost management and margin discipline.

Revenue · FY 2025
₹130.23 Cr ▼ 21.66%
Profit · FY 2025
-₹6.11 Cr ▼ 158.6%
EBITDA · FY 2025
₹9.39 Cr ▼ 61.93%
Revenue₹ Cr · Consolidated0100200FY 2021: ₹21 Cr21.1FY 2021FY 2022: ₹62 Cr · +192% YoY61.6+192%FY 2022FY 2023: ₹163 Cr · +164.6% YoY163+164.6%FY 2023FY 2024: ₹166 Cr · +2% YoY166+2%FY 2024FY 2025: ₹130 Cr · -21.7% YoY130-21.7%FY 2025
Net Profit₹ Cr · Consolidated-15-10-5051015FY 2021: ₹11 Cr (loss)-11.2FY 2021FY 2022: ₹4 Cr · +139.6% YoY4.4+139.6%FY 2022FY 2023: ₹12 Cr · +168.7% YoY11.9+168.7%FY 2023FY 2024: ₹10 Cr · -12.6% YoY10.4-12.6%FY 2024FY 2025: ₹6 Cr (loss) · -158.6% YoY-6.1FY 2025
Quarterly Revenue₹ Cr · vs same quarter last year0204060Q1'25: ₹32 Cr31.5Q1'25Q2'25: ₹31 Cr30.8Q2'25Q3'25: ₹17 Cr17.3Q3'25Q4'25: ₹51 Cr50.6Q4'25Q1'26: ₹29 Cr · -7.7% YoY29.1-7.7%Q1'26Q2'26: ₹36 Cr · +16.7% YoY35.9+16.7%Q2'26Q3'26: ₹35 Cr · +102.2% YoY35+102.2%Q3'26
Metrics FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
Revenue from Operations ₹130.23 Cr ₹166.23 Cr ₹162.93 Cr ₹61.57 Cr ₹21.09 Cr
Other Income ₹3.13 Cr ₹1.21 Cr ₹4.49 Cr ₹22.09 Lakh ₹26.5 Lakh
Total Income ₹133.35 Cr ₹167.44 Cr ₹167.41 Cr ₹61.79 Cr ₹21.35 Cr
Cost of Materials Consumed ₹82.77 Cr ₹103.22 Cr ₹102.21 Cr ₹41.04 Cr ₹15.77 Cr
Purchases of Stock-in-Trade ₹0 ₹0 ₹0 ₹0 ₹0
Changes in Inventories ₹0 -₹6.09 Cr ₹0 ₹0 ₹0
Employee Benefit Expense ₹20.47 Cr ₹23.93 Cr ₹23.54 Cr ₹10.22 Cr ₹5.94 Cr
Finance Costs ₹11.76 Cr ₹9.88 Cr ₹5.56 Cr ₹1.88 Cr ₹1.96 Cr
Depreciation & Amortisation ₹3.37 Cr ₹3.8 Cr ₹3.35 Cr ₹65.94 Lakh ₹45.82 Lakh
Other Expenses ₹20.73 Cr ₹21.72 Cr ₹19.95 Cr ₹3.54 Cr ₹4.33 Cr
Total Expenses ₹139.1 Cr ₹156.47 Cr ₹154.61 Cr ₹57.34 Cr ₹28.46 Cr
Profit Before Exceptional Items & Tax -₹5.74 Cr ₹10.97 Cr ₹12.81 Cr ₹4.45 Cr -₹7.11 Cr
Exceptional Items ₹0 ₹0 -₹50 Lakh ₹0 -₹4.11 Cr
Profit Before Tax -₹5.74 Cr ₹10.97 Cr ₹12.31 Cr ₹4.45 Cr -₹11.21 Cr
Total Tax Expense ₹36.4 Lakh ₹55.19 Lakh ₹37.52 Lakh ₹1.24 Lakh ₹0
Net Profit -₹6.11 Cr ₹10.42 Cr ₹11.93 Cr ₹4.44 Cr -₹11.21 Cr
  attributable to Owners - ₹0 ₹8.74 Cr ₹4.43 Cr -₹11.12 Cr
  attributable to NCI - ₹0 ₹3.19 Cr ₹1.2 Lakh -₹9.29 Lakh
Other Comprehensive Income ₹0 ₹0 ₹0 ₹0 ₹0
Total Comprehensive Income -₹6.11 Cr ₹10.42 Cr ₹11.93 Cr ₹4.44 Cr -₹11.21 Cr
EBITDA (computed) ₹9.39 Cr ₹24.66 Cr ₹21.71 Cr ₹6.99 Cr -₹4.69 Cr
Basic EPS ₹-1.35 ₹1.40 ₹2.55 ₹1.30 ₹-3.15
Diluted EPS ₹-1.35 ₹1.40 ₹2.05 ₹1.30 ₹-3.15
Metrics FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
Total Assets ₹268.17 Cr ₹235.03 Cr ₹155.96 Cr ₹51.4 Cr ₹40.05 Cr
Non-current Assets ₹90.23 Cr ₹90.05 Cr ₹78.44 Cr ₹30.46 Cr ₹30.43 Cr
Current Assets ₹177.94 Cr ₹144.98 Cr ₹77.52 Cr ₹20.94 Cr ₹9.62 Cr
Property, Plant & Equipment ₹34.34 Cr ₹39.08 Cr ₹34.11 Cr ₹12.67 Cr ₹11.53 Cr
Inventories ₹41.34 Cr ₹42.35 Cr ₹12.21 Cr ₹1.53 Cr ₹1.09 Cr
Trade Receivables ₹58.69 Cr ₹39.53 Cr ₹29.97 Cr ₹14.1 Cr ₹4.77 Cr
Cash & Equivalents ₹28.82 Lakh ₹58.21 Lakh ₹3.04 Cr ₹5.24 Lakh ₹8.01 Lakh
Equity (Net Worth) ₹99.92 Cr ₹76.27 Cr ₹48.35 Cr ₹24.57 Cr ₹20.08 Cr
Equity Share Capital ₹45.54 Cr ₹45.54 Cr ₹43.48 Cr ₹34.23 Cr ₹34.23 Cr
Borrowings (Non-current) ₹65.42 Cr ₹66.6 Cr ₹29.37 Cr ₹6.79 Cr ₹8.15 Cr
Borrowings (Current) ₹71.66 Cr ₹41.07 Cr ₹33.37 Cr ₹11.1 Cr ₹7.38 Cr
Total Debt (computed) ₹137.07 Cr ₹107.66 Cr ₹62.75 Cr ₹17.89 Cr ₹15.54 Cr
Current Liabilities ₹102.48 Cr ₹87.07 Cr ₹71.91 Cr ₹19.48 Cr ₹11.81 Cr
Total Liabilities ₹168.25 Cr ₹158.76 Cr ₹107.61 Cr ₹26.83 Cr ₹19.97 Cr
Metrics FY 2025 FY 2024 FY 2023 FY 2022
Operating Cash Flow -₹6.74 Cr -₹30.35 Cr ₹16.19 Cr ₹4.13 Cr
Investing Cash Flow ₹24.74 Cr -₹16.34 Cr -₹47.39 Cr -₹55.79 Lakh
Financing Cash Flow -₹18.3 Cr ₹44.24 Cr ₹32.74 Cr -₹2.74 Cr
Capital Expenditure ₹1.38 Cr ₹16.3 Cr ₹18.25 Cr ₹1.19 Cr
Free Cash Flow (computed) -₹8.12 Cr -₹46.66 Cr -₹2.07 Cr ₹2.94 Cr
Dividends Paid ₹0 ₹0 ₹0 ₹0
Net Change in Cash -₹29.39 Lakh -₹2.45 Cr ₹1.53 Cr ₹82.39 Lakh
The cash-flow statement became part of the exchange results-filing format in FY2022 - earlier years were not filed and are hidden.
Metrics Q3 FY26 Q2 FY26 Q1 FY26 Q4 FY25 Q3 FY25 Q2 FY25 Q1 FY25
Revenue from Operations ₹35.01 Cr ₹35.95 Cr ₹29.1 Cr ₹50.57 Cr ₹17.32 Cr ₹30.81 Cr ₹31.53 Cr
Other Income ₹83.08 Lakh ₹1.8 Cr ₹1.06 Cr ₹2.78 Cr ₹38,000 ₹30.13 Lakh ₹4.43 Lakh
Total Income ₹35.85 Cr ₹37.75 Cr ₹30.16 Cr ₹53.35 Cr ₹17.32 Cr ₹31.11 Cr ₹31.57 Cr
Cost of Materials Consumed ₹26.1 Cr ₹21.94 Cr ₹20.76 Cr ₹38.96 Cr ₹10.05 Cr ₹17.09 Cr ₹16.67 Cr
Purchases of Stock-in-Trade ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Changes in Inventories ₹0 ₹0 ₹0 ₹1.22 Cr ₹8.64 Lakh -₹2.22 Cr ₹91.33 Lakh
Employee Benefit Expense ₹3.2 Cr ₹3.97 Cr ₹2.69 Cr ₹6.19 Cr ₹3.42 Cr ₹5.14 Cr ₹5.72 Cr
Finance Costs ₹2.47 Cr ₹1.89 Cr ₹2.17 Cr ₹7.07 Cr ₹1.03 Cr ₹1.42 Cr ₹2.25 Cr
Depreciation & Amortisation ₹1.01 Cr ₹1.3 Cr ₹85.82 Lakh -₹1.72 Cr ₹1.46 Cr ₹2.79 Cr ₹82.74 Lakh
Other Expenses ₹2.93 Cr ₹7.59 Cr ₹3.47 Cr ₹9.93 Cr ₹84.96 Lakh ₹5.69 Cr ₹4.25 Cr
Total Expenses ₹35.7 Cr ₹36.69 Cr ₹29.95 Cr ₹61.66 Cr ₹16.89 Cr ₹29.92 Cr ₹30.63 Cr
Profit Before Exceptional Items & Tax ₹14.26 Lakh ₹1.06 Cr ₹20.87 Lakh -₹8.32 Cr ₹43.28 Lakh ₹1.2 Cr ₹94.46 Lakh
Exceptional Items ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Profit Before Tax ₹14.26 Lakh ₹1.06 Cr ₹20.87 Lakh -₹8.32 Cr ₹43.28 Lakh ₹1.2 Cr ₹94.46 Lakh
Total Tax Expense ₹2.7 Lakh ₹14.83 Lakh ₹5.22 Lakh ₹20.67 Lakh ₹8.13 Lakh -₹1.85 Lakh ₹9.45 Lakh
Net Profit ₹11.56 Lakh ₹91.21 Lakh ₹15.65 Lakh -₹8.53 Cr ₹35.15 Lakh ₹1.22 Cr ₹85.01 Lakh
  attributable to Owners ₹6.36 Lakh - - - ₹23.86 Lakh - ₹0
  attributable to NCI ₹5.2 Lakh - - - ₹11.29 Lakh - ₹0
Other Comprehensive Income ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Total Comprehensive Income ₹11.56 Lakh ₹91.21 Lakh ₹15.65 Lakh -₹8.53 Cr ₹35.15 Lakh ₹1.22 Cr ₹85.01 Lakh
EBITDA (computed) ₹3.62 Cr ₹4.25 Cr ₹3.24 Cr -₹2.96 Cr ₹2.92 Cr ₹5.41 Cr ₹4.02 Cr
Basic EPS ₹0.01 ₹0.09 ₹0.03 ₹-1.42 ₹0.05 ₹0.13 ₹0.10
Diluted EPS ₹0.01 ₹0.09 ₹0.03 ₹-1.42 ₹0.05 ₹0.13 ₹0.10
Latest 7 quarters shown.
Metrics FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Revenue from Operations ₹37.77 Cr ₹62.32 Cr ₹74.48 Cr ₹57.99 Cr ₹21.01 Cr ₹49.9 Cr ₹46.98 Cr
Other Income ₹3.52 Cr ₹3.62 Cr ₹64.19 Lakh ₹22.09 Lakh ₹26.34 Lakh ₹19 Lakh ₹45.04 Lakh
Total Income ₹41.29 Cr ₹65.94 Cr ₹75.12 Cr ₹58.21 Cr ₹21.27 Cr ₹50.09 Cr ₹47.43 Cr
Cost of Materials Consumed ₹14.78 Cr ₹35.15 Cr ₹41.49 Cr ₹39.71 Cr ₹15.76 Cr ₹31.98 Cr ₹29.96 Cr
Purchases of Stock-in-Trade ₹0 ₹0 ₹0 ₹0 ₹0 ₹50 Lakh ₹0
Changes in Inventories ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Employee Benefit Expense ₹13.24 Cr ₹15.69 Cr ₹17.5 Cr ₹8.97 Cr ₹5.71 Cr ₹11.35 Cr ₹11.73 Cr
Finance Costs ₹7.32 Cr ₹4.83 Cr ₹2.78 Cr ₹1.88 Cr ₹1.96 Cr ₹1.15 Cr ₹1.12 Cr
Depreciation & Amortisation ₹1.02 Cr ₹1.45 Cr ₹93.26 Lakh ₹34.43 Lakh ₹40.25 Lakh ₹1.01 Cr ₹1.09 Cr
Other Expenses ₹4.27 Cr ₹5.81 Cr ₹6.84 Cr ₹3.07 Cr ₹4.21 Cr ₹3.29 Cr ₹3.17 Cr
Total Expenses ₹40.64 Cr ₹62.93 Cr ₹69.54 Cr ₹53.98 Cr ₹28.05 Cr ₹49.28 Cr ₹47.07 Cr
Profit Before Exceptional Items & Tax ₹64.63 Lakh ₹3.01 Cr ₹5.58 Cr ₹4.23 Cr -₹6.78 Cr ₹81 Lakh ₹36.34 Lakh
Exceptional Items ₹0 ₹0 -₹50 Lakh ₹0 -₹4.11 Cr ₹0 ₹0
Profit Before Tax ₹64.63 Lakh ₹3.01 Cr ₹5.08 Cr ₹4.23 Cr -₹10.89 Cr ₹81 Lakh ₹36.34 Lakh
Total Tax Expense -₹80 Lakh ₹1.55 Cr ₹2.25 Lakh ₹0 ₹0 ₹0 ₹31.58 Lakh
Net Profit ₹1.45 Cr ₹1.46 Cr ₹5.06 Cr ₹4.23 Cr -₹10.89 Cr ₹81 Lakh ₹4.76 Lakh
Other Comprehensive Income ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Total Comprehensive Income ₹1.45 Cr ₹1.46 Cr ₹5.06 Cr ₹4.23 Cr -₹10.89 Cr ₹81 Lakh ₹4.76 Lakh
EBITDA (computed) ₹8.99 Cr ₹9.28 Cr ₹9.3 Cr ₹6.45 Cr -₹4.41 Cr ₹2.97 Cr ₹2.57 Cr
Basic EPS ₹0.00 ₹0.32 ₹1.48 ₹1.23 ₹-3.18 ₹0.24 ₹0.01
Diluted EPS ₹0.00 ₹0.32 ₹1.20 ₹1.23 ₹-3.18 ₹0.24 ₹0.01
Metrics FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Total Assets ₹130.68 Cr ₹126.01 Cr ₹100.3 Cr ₹49.43 Cr ₹39.85 Cr ₹51.47 Cr ₹50.16 Cr
Non-current Assets ₹50.05 Cr ₹54.5 Cr ₹50.97 Cr ₹29.41 Cr ₹30.34 Cr ₹32.28 Cr ₹29.58 Cr
Current Assets ₹80.62 Cr ₹71.5 Cr ₹49.33 Cr ₹20.02 Cr ₹9.51 Cr ₹19.2 Cr ₹20.58 Cr
Property, Plant & Equipment ₹12.83 Cr ₹17.82 Cr ₹19.97 Cr ₹11.49 Cr ₹11.28 Cr ₹13.53 Cr ₹14.02 Cr
Inventories ₹1.69 Cr ₹1.92 Cr ₹1.86 Cr ₹1.37 Cr ₹1.08 Cr ₹5.07 Cr ₹8.52 Cr
Trade Receivables ₹16.46 Cr ₹17.6 Cr ₹16.23 Cr ₹12.88 Cr ₹4.77 Cr ₹7.04 Cr ₹7.93 Cr
Cash & Equivalents ₹6.21 Lakh ₹26.29 Lakh ₹61.9 Lakh ₹3.62 Lakh ₹3.99 Lakh ₹11.08 Lakh ₹2.82 Lakh
Equity (Net Worth) ₹55.33 Cr ₹54.52 Cr ₹51.15 Cr ₹24.18 Cr ₹19.95 Cr ₹30.84 Cr ₹30.03 Cr
Equity Share Capital ₹45.54 Cr ₹45.54 Cr ₹43.48 Cr ₹34.23 Cr ₹34.23 Cr ₹34.23 Cr ₹34.23 Cr
Borrowings (Non-current) ₹13.64 Cr ₹14.88 Cr ₹9.76 Cr ₹6.79 Cr ₹8.15 Cr ₹6.94 Cr ₹7.1 Cr
Borrowings (Current) ₹48.02 Cr ₹44.51 Cr ₹25.51 Cr ₹9.95 Cr ₹7.28 Cr ₹6.8 Cr ₹6.75 Cr
Total Debt (computed) ₹61.66 Cr ₹59.39 Cr ₹35.27 Cr ₹16.73 Cr ₹15.43 Cr ₹13.74 Cr ₹13.85 Cr
Current Liabilities ₹61.48 Cr ₹51.52 Cr ₹33.06 Cr ₹18.46 Cr ₹11.73 Cr ₹13.68 Cr ₹13.02 Cr
Total Liabilities ₹75.35 Cr ₹71.49 Cr ₹49.15 Cr ₹25.26 Cr ₹19.9 Cr ₹20.64 Cr ₹20.13 Cr
Metrics FY 2025 FY 2024 FY 2023 FY 2022
Operating Cash Flow ₹17.35 Cr ₹26.09 Cr ₹8.39 Cr ₹3.48 Cr
Investing Cash Flow -₹1.34 Cr -₹7.22 Cr -₹14.09 Cr ₹58.63 Lakh
Financing Cash Flow -₹16.22 Cr -₹19.23 Cr ₹4.87 Cr -₹3.25 Cr
Capital Expenditure ₹85.07 Lakh ₹6.34 Cr ₹1.9 Cr ₹6.31 Lakh
Free Cash Flow (computed) ₹16.5 Cr ₹19.75 Cr ₹6.49 Cr ₹3.42 Cr
Dividends Paid ₹0 ₹0 ₹0 ₹0
Net Change in Cash -₹20.08 Lakh -₹35.61 Lakh -₹82.64 Lakh ₹81.87 Lakh
The cash-flow statement became part of the exchange results-filing format in FY2022 - earlier years were not filed and are hidden.
Metrics Q3 FY26 Q2 FY26 Q1 FY26 Q4 FY25 Q3 FY25 Q2 FY25 Q1 FY25
Revenue from Operations ₹5.2 Cr ₹5.93 Cr ₹6.69 Cr ₹9.28 Cr ₹8.19 Cr ₹9.51 Cr ₹10.79 Cr
Other Income ₹67.66 Lakh ₹1.82 Cr ₹89.16 Lakh ₹93.41 Lakh ₹66.21 Lakh ₹89.38 Lakh ₹1.03 Cr
Total Income ₹5.88 Cr ₹7.75 Cr ₹7.58 Cr ₹10.22 Cr ₹8.85 Cr ₹10.4 Cr ₹11.82 Cr
Cost of Materials Consumed ₹2.04 Cr ₹3.06 Cr ₹3.35 Cr ₹2.8 Cr ₹3.34 Cr ₹3.8 Cr ₹4.85 Cr
Purchases of Stock-in-Trade ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Changes in Inventories ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Employee Benefit Expense ₹1.38 Cr ₹1.56 Cr ₹1.5 Cr ₹3.3 Cr ₹2.69 Cr ₹3.2 Cr ₹4.04 Cr
Finance Costs ₹1.09 Cr ₹99.22 Lakh ₹1.32 Cr ₹2.39 Cr ₹1.52 Cr ₹1.89 Cr ₹1.52 Cr
Depreciation & Amortisation ₹14.23 Lakh ₹16.51 Lakh ₹15.25 Lakh ₹6.41 Lakh ₹32.34 Lakh ₹31.76 Lakh ₹31.98 Lakh
Other Expenses ₹1.12 Cr ₹1.36 Cr ₹1.08 Cr ₹1.46 Cr ₹82.36 Lakh ₹1.06 Cr ₹92.93 Lakh
Total Expenses ₹5.77 Cr ₹7.13 Cr ₹7.41 Cr ₹10.01 Cr ₹8.71 Cr ₹10.27 Cr ₹11.65 Cr
Profit Before Exceptional Items & Tax ₹10.72 Lakh ₹62.62 Lakh ₹17.03 Lakh ₹20.24 Lakh ₹14.18 Lakh ₹13.16 Lakh ₹17.05 Lakh
Exceptional Items ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Profit Before Tax ₹10.72 Lakh ₹62.62 Lakh ₹17.03 Lakh ₹20.24 Lakh ₹14.18 Lakh ₹13.16 Lakh ₹17.05 Lakh
Total Tax Expense ₹2.7 Lakh ₹15.79 Lakh ₹4.26 Lakh ₹0 ₹3.57 Lakh ₹3.27 Lakh ₹4.33 Lakh
Net Profit ₹8.02 Lakh ₹46.83 Lakh ₹12.77 Lakh ₹20.24 Lakh ₹10.61 Lakh ₹9.89 Lakh ₹12.72 Lakh
Other Comprehensive Income ₹0 ₹0 ₹0 ₹0 ₹0 ₹0 ₹0
Total Comprehensive Income ₹8.02 Lakh ₹46.83 Lakh ₹12.77 Lakh ₹20.24 Lakh ₹10.61 Lakh ₹9.89 Lakh ₹12.72 Lakh
EBITDA (computed) ₹1.34 Cr ₹1.78 Cr ₹1.64 Cr ₹2.66 Cr ₹1.99 Cr ₹2.33 Cr ₹2.01 Cr
Basic EPS ₹0.01 ₹0.10 ₹0.03 ₹0.00 ₹0.02 ₹0.02 ₹0.03
Diluted EPS ₹0.01 ₹0.10 ₹0.03 ₹0.00 ₹0.02 ₹0.02 ₹0.03
Latest 7 quarters shown.
Want more history and ratios?
You're viewing the latest exchange-filed financials for Indrayani Biotech Limited. The full report adds 10+ years of line-item history, 20+ ratios, peer benchmarks and a downloadable PDF.
10+ years of history 20+ ratios & benchmarks Downloadable PDF

Shareholding Pattern of Indrayani Biotech Limited

As per the shareholding pattern filed with BSE for the quarter ended Mar 2026, promoters hold 33.26%, domestic institutional investors hold 3.13%, retail and other public shareholders hold 63.61% of Indrayani Biotech Limited. The company had 25,509 shareholders on record.

Promoters: 33.26%DII (Domestic Institutional): 3.13%Retail & Others: 63.61%
Mar 2026
QUARTER
33.26% Promoters
3.13% DII (Domestic Institutional)
63.61% Retail & Others
Promoter holding - history
Now 33.26% · Mar 2026High 44.89% · Jun 2023Low 33.26% · Sep 2025
32%35.5%39%42.5%46%Jun 2023Dec 2023Jun 2024Dec 2024Jun 2025Dec 2025Jun 2023: 44.89%Sep 2023: 44.84%Dec 2023: 33.63%Mar 2024: 33.57%Jun 2024: 33.48%Sep 2024: 33.40%Dec 2024: 33.28%Mar 2025: 33.28%Jun 2025: 33.28%Sep 2025: 33.26%Dec 2025: 33.26%Mar 2026: 33.26%44.89%33.26%33.26%
Shareholding trend - last 6 quarters
Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Promoters33.26%33.26%33.26%33.28%33.28%33.28%
Public66.74%66.74%66.74%66.72%66.72%66.72%
Shareholding history - year on year (as at 31 March)
Mar 2026Mar 2025Mar 2024
Promoters33.26%33.28%33.57%
Public66.74%66.72%66.43%
Promoter change (YoY, %pts)-0.02-0.29-

Group Structure of Indrayani Biotech Limited

Indrayani Biotech Limited has 9 subsidiary companies. This group structure data is as of FY 2023. The corporate group structure reflects Indrayani Biotech Limited's business expansion strategy and organizational complexity.

9
Subsidiary companies
Key Subsidiaries
Company Name CIN Shares Held
Hsl Agri Solutions Limited U01100TN2018PLC121939 -
Dindigul Farm Product Private Limited U15200TZ2010PTC016407 -
Matrix Boilers Private Limited U28131TN2006PTC060358 -
Ibl Investments Limited U65990TN2022PLC152486 -
Hslprime Properties Private Limited U70103TN2017PTC114104 -
Healthway India Private Limited U74900TN2013PTC091433 -

Showing major subsidiaries. Total: 9.

Charges & Borrowings of Indrayani Biotech Limited

Open charges
₹22.15 Cr
Satisfied charges
₹63 Lakh
Breakdown by lending institutions
Others₹11.78 Cr
Axis Bank Limited₹10.00 Cr
Hdfc Bank Limited₹0.37 Cr
Latest charge details
DateLenderAmountStatus
26 Feb 2024 Hdfc Bank Limited ₹37 Lakh Open
21 Jan 2023 Others ₹7 Cr Open
08 Dec 2022 Others ₹19 Lakh Open
16 Nov 2022 Others ₹8.58 Lakh Open
26 Apr 2022 Others ₹21.28 Lakh Open

Total charge records: 13 View all charges

Employees and EPFO Compliance at Indrayani Biotech Limited

Indrayani Biotech Limited has a workforce of 445 employees as of Apr 09, 2024.

Employee count
445
Active EPFO establishments
2
Employee growth
9.61%
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026

Employee Count & EPFO Data of Indrayani Biotech Limited

Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.

Monthly employee headcount & PF contributions
EPFO establishment details & ECR filing status
Year-wise workforce analytics & attrition trends
PF exemption, coverage & compliance verification

GST Compliance of Indrayani Biotech Limited

XX%
Compliant
GSTR-1
GSTR-3B
GSTR-9
MH
KA
UP
TN
TS

GSTIN & GST Filing Data of Indrayani Biotech Limited

Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.

GSTIN registrations & state-wise presence
Filing compliance - GSTR-1, GSTR-3B, GSTR-9
HSN/SAC codes with goods & services details
Taxpayer type, jurisdiction & business constitution

Credit Ratings, Litigation & Regulatory Alerts for Indrayani Biotech Limited

Credit rating
AAA
AA+
AA
AA-
! !
2015 2017 2019 2021 2023
Litigation
District Court 35
High Court 45
Supreme Court 0
NCLT / NCLAT 0
Pending
Disposed
Regulatory alerts
GSTIN Cancelled
Andhra Pradesh
GSTIN Cancelled
Telangana (on application)
EPFO Delay
12 months delay - Haryana
Violations via Directors
20 MCA + 19 Bank defaults

Credit Ratings, Legal Cases & Regulatory Alerts of Indrayani Biotech Limited

Access complete credit rating history, litigation records, regulatory alerts, and compliance data.

Credit rating history across CARE, ICRA, Brickwork & India Ratings
Instrument-wise ratings, outlook & action timeline
Court-wise litigation (District, High Court, Supreme Court, NCLT)
Group company & common directorship litigation
Statutory compliance alerts (GSTIN, EPFO, ROC)
Director & company violations (MCA, SEBI, Banks, BSE/NSE)

MSME Payment Delays by Indrayani Biotech Limited

MSME Payment Delays by Indrayani Biotech Limited

Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.

Amounts outstanding to MSME suppliers
Delay periods & reasons for delayed payments
Half-yearly MSME-1 filing history
Vendor-payment behaviour as a counterparty risk signal

Subsidiaries & Group Companies of Indrayani Biotech Limited

Subsidiaries & Group Companies of Indrayani Biotech Limited

See the full corporate group - holding company, subsidiaries, associates and joint ventures of Indrayani Biotech Limited with ownership details.

Holding & parent company details
Subsidiaries & step-down subsidiaries with % holding
Associates & joint ventures with partner details
Investments in other entities year-on-year

MCA Filings & Documents of Indrayani Biotech Limited

MCA Filings & Documents of Indrayani Biotech Limited

Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.

Incorporation documents, MoA & AoA
Annual returns (MGT-7) & financial statements (AOC-4)
Charge filings (CHG-1, CHG-4) & resolutions
Complete document index with filing dates

Recent Activity on Indrayani Biotech Limited

Directors
29 Apr 2025
Dhinakaran Rajagopal was appointed as a Cfo on 29 Apr 2025 & has been associated with this company since 1 year 2 months.
Directors
03 Apr 2025
Dhinakaran Rajagopal was appointed as a CFO on 03 Apr 2025 & has been associated with this company since 1 year 3 months.
Charges
18 Feb 2025
A charge with Others of Rs. 7.00 Cr registered on 21 Jan 2023 with Charge ID 100668296 was modified on 18 Feb 2025.
Activity
22 Aug 2024
Indrayani Biotech Limited last Annual general meeting of members was held on 22 Aug 2024 as per latest MCA records.
Activity
31 Mar 2024
Indrayani Biotech Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai.
Charges
26 Feb 2024
A charge with Hdfc Bank Limited amounted to Rs. 0.37 Cr with Charge ID 100883173 was registered on 26 Feb 2024.

Recent News on Indrayani Biotech Limited

Frequently Asked Questions about Indrayani Biotech Limited

Indrayani Biotech Limited is an active public limited company in the agriculture sector based in Chennai, Tamil Nadu, India. It was incorporated on 09 March 1992 (34+ years old) and is registered under CIN L40100TN1992PLC129301. Listed on BSE: 526445. The company has 445 employees.

Indrayani Biotech Limited reported revenue of ₹167.44 Cr for FY 2024 (up 0.00% YoY).

The current directors of Indrayani Biotech Limited are:

The primary industry of Indrayani Biotech Limited is agriculture. The company specifically operates in fertilizers and soil enhancers. The company is currently active in this sector.

Yes. Indrayani Biotech Limited is listed on BSE with code 526445.

Indrayani Biotech Limited can be reached at the registered office: Block 1 Module No.33 3Rd Floor Sidco Electronic Complex Thiru Vi Ka Industrial Estate G, Uindy, Chennai, Tamil Nadu, India – 600032, or through the website indrayani.com.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available